Lozanoc

DRUG2 trials

Sponsors

Mayne Pharma International Pty Ltd

Conditions

Neutropenia

Phase 2

Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis

CompletedNCT02755857

Mayne Pharma International Pty LtdNeutropenia

Start: 2016-07-31End: 2017-01-31Updated: 2018-10-26

Phase 4

Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg

CompletedNCT02621905

Mayne Pharma International Pty LtdNeutropenia

Start: 2015-11-30End: 2016-12-31Updated: 2018-10-26